PURPOSE OF REVIEW: Communicable diseases were traditionally the major cause of public health concern in Asian countries, most of which were less developed. With industrialization and associated lifestyle changes during the past few decades, however, noncommunicable diseases similar to those that affect Western societies have emerged in Asian countries. The purpose of the review was to examine recent evidence about the burden and factors associated with @entity101 and @entity740 ( @entity740 ) in Asian countries. RECENT FINDINGS: @entity101 has become one of the leading causes of mortality in Asia. Although its prevalence continues to rise, it remains under-diagnosed and under-treated. @entity740 is becoming increasingly common mainly due to an increase in risk factors such as @entity101 , @entity6 , and @entity28 . Treatment of advanced @entity740 is overwhelmingly burdensome in a resource poor environment. Barriers to early detection of @entity740 in Asians include the fact that equations to estimate the glomerular filtration rate have not been validated in this population, and the uncertainty about appropriate glomerular filtration rate cutoff values to define @entity740 . SUMMARY: Concerted efforts are needed to develop and implement cost-effective strategies for prevention and treatment of @entity101 and @entity740 in Asian countries. More research is needed on these conditions in these populations.

XXXX and kidney disease in Asia.

@entity28 :: ('MESH:D009765', 'Disease') :: ['obesity'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes'] @entity101 :: ('MESH:D006973', 'Disease') :: ['high blood pressure', 'hypertension', 'Hypertension'] @entity740 :: ('MESH:D051436', 'Disease') :: ['CKD', 'chronic kidney disease']
@entity101 :: (MESH:D006973,Disease) :: ['Hypertension']
